BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33054165)

  • 1. Isopedopeptins A-H: Cationic Cyclic Lipodepsipeptides from
    Nord C; Bjerketorp J; Levenfors JJ; Cao S; Strömstedt AA; Guss B; Larsson R; Hughes D; Öberg B; Broberg A
    ACS Chem Biol; 2020 Nov; 15(11):2937-2944. PubMed ID: 33054165
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Isolation of Multidrug-Resistant
    Bjerketorp J; Levenfors JJ; Nord C; Guss B; Öberg B; Broberg A
    Front Microbiol; 2021; 12():642829. PubMed ID: 33717041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
    Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
    J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the pharmacodynamic profile of intravenous antibiotics against prevalent Gram-negative organisms collected in Colombia.
    Villegas MV; Briceno DF; Ruiz SJ; Furtado GH; Nicolau DP
    Braz J Infect Dis; 2011; 15(5):413-9. PubMed ID: 22230846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of Vector Autoregressive and Linear Transfer Models to Follow Up the Antibiotic Resistance Spiral in Gram-negative Bacteria From Cephalosporin Consumption to Colistin Resistance.
    Tóth H; Fésűs A; Kungler-Gorácz O; Balázs B; Majoros L; Szarka K; Kardos G
    Clin Infect Dis; 2019 Sep; 69(8):1410-1421. PubMed ID: 30561543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibacterial and antibiotic-resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against Gram-negative multi-drug resistant phenotypes.
    Seukep JA; Sandjo LP; Ngadjui BT; Kuete V
    BMC Complement Altern Med; 2016 Jul; 16():193. PubMed ID: 27386848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016.
    Jarlier V; Diaz Högberg L; Heuer OE; Campos J; Eckmanns T; Giske CG; Grundmann H; Johnson AP; Kahlmeter G; Monen J; Pantosti A; Rossolini GM; van de Sande-Bruinsma N; Vatopoulos A; Żabicka D; Žemličková H; Monnet DL; Simonsen GS;
    Euro Surveill; 2019 Aug; 24(33):. PubMed ID: 31431208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
    Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of carbapenem-resistant Gram-negative bacteria from Tamil Nadu.
    Nachimuthu R; Subramani R; Maray S; Gothandam KM; Sivamangala K; Manohar P; Bozdogan B
    J Chemother; 2016 Oct; 28(5):371-4. PubMed ID: 26198414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
    Lee JY; Choi MJ; Choi HJ; Ko KS
    Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 18. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
    Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
    Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
    Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
    Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.